3VXT image
Deposition Date 2012-09-20
Release Date 2013-10-23
Last Version Date 2024-10-30
Entry Detail
PDB ID:
3VXT
Keywords:
Title:
T36-5 TCR specific for HLA-A24-Nef134-10
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.50 Å
R-Value Free:
0.27
R-Value Work:
0.23
Space Group:
P 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:T36-5 TCR alpha chain
Chain IDs:A (auth: C), C (auth: A)
Chain Length:205
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:T36-5 TCR beta chain
Chain IDs:B (auth: D), D (auth: B)
Chain Length:242
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Structure of TCR and antigen complexes at an immunodominant CTL epitope in HIV-1 infection
SCI REP 3 3097 3097 (2013)
PMID: 24192765 DOI: 10.1038/srep03097

Abstact

We investigated the crystal structure of an HLA-A*2402-restricted CTL epitope in the HIV-1 nef gene (Nef134-10) before (pHLA) or after TCR docking. The wild type epitope and two escape mutants were included in the study. Y135F was an early-appearing major mutation, while F139L was a late-appearing mutation which was selected in the patients without Y135F. F139 was an eminent feature of the Nef134-10 epitope. Wild type-specific TCR was less fit to F139L mutant suggesting that F139L is an escape from the CTL against the wild type epitope. Although Y135F mutation disrupted the hydrogen bond to HLA-A*2402 His70, newly formed hydrogen bond between T138 and His70 kept the conformation of the epitope in the reconstituted pMHC. TCR from Y135F- or dually-specific CTL had unique mode of binding to the mutant epitope. Y135F has been reported as a processing mutant but CTL carrying structurally adequate TCR can be found in the patients.

Legend

Protein

Chemical

Disease

Primary Citation of related structures